Icon

BARACLUDE (nda021797)- (0.5MG,1MG)

ENTECAVIR BRISTOL MYERS SQUIBB
0.5MG,1MG
Yes No
2015-Aug-21 Expired
None None
None No
BARACLUDE is a hepatitis B virus nucleoside analogue reverse transcriptase inhibitor indicated for the treatment of chronic hepatitis B virus infection in adults and children at least 2 years of age with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.
12 0 11
Total Other Developers 1
Drugs with Suitability No
0.5MG ** ** - - 8
1MG ** ** - - 8
NDA Sales Available Total Generic Sales Available
Yes 10
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** **** *** * ****** **** ******* *********** **** *, **. **.: ***, ***, *** & ***, ***** *********** ***, ********* *******, ************, ********* ******, ***** (***) ***
****** ****** ******** ****** ****** *** *********** ******** ******** ****, *** ********* ****, *********, , ******* (***) ***
****** ********* ****** ********* ****** ******* *********** ****-***, ** **. ***/*, ***/*, ***/*, ***/* & ***/*, **** ** **** ***, *****, ***** ********** ****, *********, ********* ******, ************, ********* ******, ***** (***) ***
****** ****** ****** ****** *************** ** *** ****, *** *********** ** ********** **, **********, *** **** (**) *****-****, ****** ****** (***) ***
****** ***** ****** ***** ************ ******* *********** **** **. *-*/*&* *******, (******* ******** ****) ******, ******* ***** *.*. **. **, ***-******, ****-*********, *********, ******* ******, ***** (***) ***
****** ***** ***** ******* *********** **** **. * &** ****** ******* ******** ****, ***** **, ********* ****, ****** ******* ******, ***** (***) ***
****** ***** ***** ******* *** *********** **** *-*, *-**, *-** **** ********** ****, ******** *******, ******-*****, ****, *********** ******, ***** (***) ***
****** **** **** ***** **** **** *****. ***. **., ***. (******** ***** *******) *********** **, **** **** **.,, ******** ****, *****, ****** (***) ***
****** ************ ******* ************ ******* *********** **** **.:*-**/*, *-*** & *-***, **** **.** ***, ******** *******, ***** ******, *******-**********, ********* ******, ***** (***) ***
****** ******** *** ******** ****** ************** **., ***. *********** ******* ****, ******, ******** ******, ***** (***) ***
****** ********* ********* (******) **., ***. (****** *****) *********** **. **, ***** **., ****** ********** ****, ****** ****, ****** ********, ****** ****, ********* ******, ***** (***) ***
****** ********** ***** ************** **., ***. *********** ***-*, ****** ****., ******, ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.